Skip to main content
. Author manuscript; available in PMC: 2015 Nov 6.
Published in final edited form as: Invest New Drugs. 2009 Aug 11;28(6):854–858. doi: 10.1007/s10637-009-9297-6

Table 1.

Patient characteristics (N=54)

Characteristic No. %
Age, years
  Median 65
  Range 19–88
Sex
  Male 28 52
  Female 26 48
ECOG performance status
  0 26 48
  1 26 48
  1 2 4
Tumor type
  Liver-(Hepatocellular carcinoma) 19 35
  Gallbladder-(Gallbladder carcinoma) 22 41
  Bile duct-(Cholangiocarcinoma) 13 24
Stage of disease
  Locally advanced 13 24
  Metastatic disease 41 76
Prior treatment
  Surgery 17 31
  Radiotherapy 2 4